Le Lézard
Classified in: Health
Subjects: PSF, CFG, MAT

Cannabis Act legislative review Expert Panel welcomes the tabling of its final report


OTTAWA, ON, March 21, 2024 /CNW/ - Today, the independent Expert Panel conducting the review of the Cannabis Act welcomed the tabling of its final report in both houses of Parliament. The report, a legislative requirement under the Act, reviews progress toward meeting the Act's objectives and recommends changes to the Act and its supporting regulations and policies.

"The Cannabis Act is a dramatic departure from prohibition, which had been the approach to controlling cannabis for the past century. After 18 months of careful consultation and discussion, we believe the legalization of cannabis was the right decision, and the 2018 framework provides a solid foundation to be built upon," said Morris Rosenberg, Chair of the Expert Panel. "That said, the legalization of cannabis was not a one-time event, and now is not the time for complacency. There is much work to be done."

The Expert Panel engaged with more than 600 people from over 250 organizations during nearly 140 engagement sessions to better understand the realities and experiences of different communities since the implementation of the Act.

After thorough consultation and consideration, the Expert Panel concluded that all levels of government have successfully established a legal industry that provides quality-controlled cannabis products to adult consumers in a relatively short period of time. The majority of Canadian cannabis consumers have moved from illicit cannabis sources to the legal market.

The Expert Panel believes legalization's greatest impact so far has been the significant reduction in the number of interactions with the criminal justice system. Since 2017, there has been a 95 per cent reduction in cannabis possession charges.

However, the Expert Panel's final report sends a strong message that the government needs to be vigilant and take further steps to protect public health and public safety and remain ready to respond to areas of concern, including the viability of the legal market.

The Expert Panel provides 54 recommendations and 11 observations to improve the cannabis framework, including:

"We want to thank the hundreds of people and organizations who were engaged in the public consultations to enrich our review of the Cannabis Act and how it has been implemented over the past five years," said Rosenberg. "The diverse perspectives, research, evidence and lived experiences shared with the panel were critical in shaping our report's recommendations."

You can read the full report here.

The Expert Panel appreciates the opportunity to have undertaken this critical review of the cannabis framework in Canada.

Cannabis Act Legislative Review Secretariat

[email protected]

SOURCE Health Canada (HC)


These press releases may also interest you

at 06:00
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

4 mai 2024
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

4 mai 2024
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...



News published on and distributed by: